Monday, April 16, 2001
Biotech and pharma companies are integrating information from genomic, biology, screening, chemistry and toxicology data, but building integrated databases to manage this information can be an expensive and time-consuming proposition. SciTegic Inc. says that its approach, called data pipelining, is the alternative to data integration.
"The volume of data is so large that the existing software for analysis is not coping," said J.R. Tozer, vice president of marketing. "A single unifying database for all independent sources of data that a biotechnology or pharmaceutical company would want to integrate is impossible."